Download presentation
Presentation is loading. Please wait.
Published byScot Banks Modified over 9 years ago
1
Generalized annular granuloma after initiation of therapy with beta blockers for glaucoma -case report- * Dermatology Department, „Carol Davila” Central University Emergency Military Hospital, Bucharest ** Dermatopathology Department, „Domina-Sana” Medical Center, Bucharest Andreea Stancu*, Aurel Doru Chirita**, Irina Margaritescu**
2
Introduction Granuloma annulare (GA) is a benign inflammatory dermatosis Granuloma annulare is a relatively common disease that occurs in all age groups Characterized: – clinically by dermal papules and annular plaques – histologically by foci of degenerative collagen associated with palisaded granulomatous inflammation
3
Clinical case We report a case of a 59 years-old women who presented with a 3 months history of pruritic papules, patches and well circumscribed plaques The lesions appeared first on the abdomen and anterior thorax and in a few days they became generalized
4
Clinical case Disseminated erythematous papules, patches, plaques
5
Granulomatous nodular dermatitis with superficial and deep perivascular infiltrate of lymphocytes and histiocytes arranged in a palisade around a locus that consists mostly of mucin, and degenerated collagen bundlles
6
Histiocytes in a palisade and scattered interstitially Degeneration of collagen Deposits of mucin
7
Interstitial lymphocytes and epithelioid histiocytes
8
Discussion Granuloma annulare can present with two different histologic patterns: Palisaded Interstitial Our case have findings of both palisaded and interstitial patterns
9
Conclusions Although the aetiology and pathogenesis of granuloma annulare are unclear, it appears likely that it represents a reaction pattern to a variety of triggering factors Because lesions started after the initiation of the B-blocker treatment we suspected a drug reaction Treatment: – discontinuation of culprit drug – Corticosteroids – PUVA-therapy
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.